Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Conditions
- Adenocarcinoma of the Esophagus
- Adenocarcinoma of the Gastroesophageal Junction
- Diffuse Adenocarcinoma of the Stomach
- Intestinal Adenocarcinoma of the Stomach
- Mixed Adenocarcinoma of the Stomach
- Squamous Cell Carcinoma of the Esophagus
- Stage IA Esophageal Cancer
- Stage IA Gastric Cancer
- Stage IB Esophageal Cancer
- Stage IB Gastric Cancer
- Stage IIA Esophageal Cancer
- Stage IIA Gastric Cancer
- Stage IIB Esophageal Cancer
- Stage IIB Gastric Cancer
- Stage IIIA Esophageal Cancer
- Stage IIIA Gastric Cancer
- Stage IIIB Esophageal Cancer
- Stage IIIB Gastric Cancer
- Stage IIIC Esophageal Cancer
- Stage IIIC Gastric Cancer
Interventions
- BIOLOGICAL: bevacizumab
- DRUG: oxaliplatin
- DRUG: leucovorin calcium
- DRUG: fluorouracil
- PROCEDURE: therapeutic conventional surgery
- OTHER: laboratory biomarker analysis
Sponsor
Fox Chase Cancer Center
Collaborators